Marijuana is currently classified by the federal government as a Schedule I substance because it fulfills all requirements that define […]
Thursday Edition of Friday Fact due to the July 4th Holiday: Federal data indicate that the vast majority of marijuana users use it exclusively as […]
Marijuana is currently classified by the federal government as a Schedule I substance because it fulfills all requirements that define […]
Thursday Edition of Friday Fact due to the July 4th Holiday: Federal data indicate that the vast majority of marijuana users use
The National Drug and Alcohol Screening Association presented a focused, credible case-in-chief on behalf of the drug and alcohol testing […]
Day three of the federal marijuana rescheduling hearing was dominated by the continued cross-examination of Dr. Cory Burchman, the retired […]
United Against Fentanyl, a DC-based drug policy organization, recently asserted that “in 2026, overdoses in the United States are at […]
A recent study in Lancet Psychiatry, which reviewed global data from 2000–2025, found that the commercialization of marijuana in the […]
This post is reprinted with permission from Sue’s Substack, by Sue Rusche. Raymond E. Bertino, MD, and colleagues at the Universities […]
The federal government’s second witness at the DEA marijuana rescheduling hearing came with a résumé that raised more questions than […]
A quiet bombshell dropped during the government witness’s testimony at the DEA marijuana rescheduling hearings over the past two days on marijuana […]
Day two of the federal marijuana rescheduling hearing delivered a pair of damaging moments for the government’s case — including […]
The National Drug and Alcohol Screening Association presented a focused, credible case-in-chief on behalf of the drug and alcohol testing […]
Day three of the federal marijuana rescheduling hearing was dominated by the continued cross-examination of Dr. Cory Burchman, the retired […]
United Against Fentanyl, a DC-based drug policy organization, recently asserted that “in 2026, overdoses in the United States are at […]
A recent study in Lancet Psychiatry, which reviewed global data from 2000–2025, found that the commercialization of marijuana in the […]
This post is reprinted with permission from Sue’s Substack, by Sue Rusche. Raymond E. Bertino, MD, and colleagues at the Universities […]
The federal government’s second witness at the DEA marijuana rescheduling hearing came with a résumé that raised more questions than […]
A quiet bombshell dropped during the government witness’s testimony at the DEA marijuana rescheduling hearings over the past two days on marijuana […]
Day Two: DEA’s Own Witness Admits Marijuana Would Have Failed the Government’s Longtime Medical Test
Day two of the federal marijuana rescheduling hearing delivered a pair of damaging moments for the government’s case — including […]